Product Information
LUCEMYRA 0.18 MG TABLET is a brand product labeled by USWM, LLC, priced at $23.2208 per EA under NDC 78670005036. Its NADAC has been published 230 times since Apr 14, 2021.
FDA first approved this application on May 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.2 mg/1
Manufacturer
USWM, LLCNDC
78670005036
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
LOFEXIDINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA209229FDA Approved
5/16/2018
TE Code
AB
On Market Since
2/9/2021
Price Statistics
The NADAC for LUCEMYRA 0.18 MG TABLET has been published 230 times since Apr 14, 2021, and over the history we have for it it has risen 18.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.2208 per EA |
|---|---|
| All-time high | $23.3109 (Jun 11, 2025) |
| All-time low | $19.6836 (Apr 14, 2021) |
| 52-week high | $23.2303 |
| 52-week low | $23.2208 |
| Median price | $23.2208 |
| Average price | $22.1664 |
| Largest weekly change | +11.5% (Jul 19, 2023) |
| Weeks tracked | 230 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
USWM, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lofexidine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LUCEMYRA 0.18 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LUCEMYRA 0.18 MG TABLET, manufactured by USWM, LLC, is $23.2208 per EA (NDC 78670005036), effective Sep 30, 2026.
How has the price of LUCEMYRA 0.18 MG TABLET changed over time?
Over the history we have for it, the NADAC for LUCEMYRA 0.18 MG TABLET has risen 18.0%. It has been tracked across 230 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for LUCEMYRA 0.18 MG TABLET?
Since Apr 14, 2021, the NADAC for LUCEMYRA 0.18 MG TABLET has ranged from a low of $19.6836 (Apr 14, 2021) to a high of $23.3109 (Jun 11, 2025), with a median of $23.2208 per EA.
Are there cheaper alternatives to LUCEMYRA 0.18 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOFEXIDINE 0.18 MG TABLET, is $7.8793 per EA — about 66% below LUCEMYRA 0.18 MG TABLET.
Who manufactures LUCEMYRA 0.18 MG TABLET?
LUCEMYRA 0.18 MG TABLET (NDC 78670005036) is labeled by USWM, LLC, and CMS classifies it as a brand product.